| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/17/2002 | CN1344552A Chinese medicine beautifying pellet and its compounding process |
| 04/17/2002 | CN1344546A Kebai Tincture and its prepn and application |
| 04/17/2002 | CN1344545A Chinese medicine prepn for treating rheumatoid arthritis and its prepn |
| 04/17/2002 | CN1344544A Specific burn-treating Chinese medicine prepn. |
| 04/17/2002 | CN1344543A 平衡液 Balanced solution |
| 04/17/2002 | CN1344542A Production process and product of instant osteocalcium composition |
| 04/17/2002 | CN1082822C Cosmetic and skin-useful composition containing water from hot spring or mineral water and agent against acne and oldening |
| 04/16/2002 | US6372501 Glucose responsive β-cell line |
| 04/16/2002 | US6372495 Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372423 For use in dioagnosis such as tests for diagnosing heparin-associated thrombocytopenia (hat), therapy |
| 04/16/2002 | US6372265 Reducing curcumin in tumeric by adding calcium ion powder to the powdery curcuma (tumeric); safely enhances tumeric's antioxidant properties; edible |
| 04/16/2002 | US6372263 Extracted from fertilized ovum of a sea water fish or a fresh water fish |
| 04/16/2002 | US6372262 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 04/16/2002 | US6372261 Process for producing Guilu ErXiangao |
| 04/16/2002 | US6372221 Immunogenic constructs comprising flaviviruses or flavivirus derivatives |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/16/2002 | US6371992 Acellular matrix grafts: preparation and use |
| 04/11/2002 | WO2002029097A2 Methods relating to polymorphisms in the human gpr10 gene |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029065A2 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | WO2002029013A1 Culture of goblet cells |
| 04/11/2002 | WO2002029010A2 Method for obtaining in vitro mammal islet cells and uses thereof |
| 04/11/2002 | WO2002028997A2 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028413A1 Bone health compositions derived from milk |
| 04/11/2002 | WO2002028406A2 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | WO2002028402A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | WO2002028332A1 Malleable paste with allograft bone reinforcement for filling bone defects |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002009650A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001085128A3 Skin protectant spray compositions |
| 04/11/2002 | WO2001082828A3 Tissue engineered testicular prosthesis and use thereof |
| 04/11/2002 | WO2001080865A3 Joint repair using mesenchymal stem cells |
| 04/11/2002 | WO2001080864A3 Chemical modification of mammalian urine and blood |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2000047762A9 Enriched central nervous system cell populations |
| 04/11/2002 | WO2000038518A9 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |
| 04/11/2002 | US20020042136 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042129 Keratinocytes and melanocytes; without any feeder cells; maintain the ability to express keratins, cytochromes, as well as other differentiation proteins |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
| 04/11/2002 | US20020042043 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 04/11/2002 | US20020041900 Chondrocyte cultures and fractions therefrom |
| 04/11/2002 | US20020041894 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis and pharmaceutical compositions and kit related thereto |
| 04/11/2002 | US20020041885 Inhibitor of immunoglobulin e antibody production |
| 04/11/2002 | US20020041884 Adenovirus formulations |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041868 Cell fusions and methods of making and using the same |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424781A1 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | CA2424738A1 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | CA2424607A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/10/2002 | EP1195439A2 Retroviral vector with heterologous sequences between the retroviral primer binding site and the retroviral splice donor site |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194554A1 Delivery of trefoil peptides |
| 04/10/2002 | EP1194529A1 Composition for the preservation of infectious recombinant adenoviruses |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194166A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 04/10/2002 | EP1194165A1 Tagged epitope protein transposable element |
| 04/10/2002 | EP1194154A1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 04/10/2002 | EP1178116A9 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344314A Sebocytes, sebocyte cell lines and applications thereof |
| 04/10/2002 | CN1344170A Methods for inactivating pathogens using broad-spectrum pulsed light |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/10/2002 | CN1344154A Absorbent article compsn. and method of use for sequestering skin irritants |
| 04/10/2002 | CN1344153A Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 04/10/2002 | CN1343512A Process for preparing vasculitis medicine |
| 04/10/2002 | CN1343508A Chinese patent medicine for treating peptic ulcer |
| 04/10/2002 | CN1343506A Chinese patent medicine for treating allergic dermatopathy |
| 04/10/2002 | CN1343505A Chinese medicine 'Ruan capsule' for treating mastoplasia |
| 04/10/2002 | CN1343496A Forest frog's egg fat injection and its preparing process |
| 04/10/2002 | CN1343495A Jadeite extracting agent and its prepn. method |
| 04/10/2002 | CN1082378C Externally-used arthralgia treating medicine and its prepn. method |
| 04/10/2002 | CN1082375C Capsule for treating gastrosia |
| 04/10/2002 | CN1082373C Medicines and drinking products for prevention and treatment gastrointestinal diseases |
| 04/10/2002 | CN1082352C Tech process of producing bifidobacterium beverage using peanuts bifidobacterium factor |
| 04/09/2002 | US6369234 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369048 Methods and compositions for inactivating viruses |